Universidad del Valle de Guatemala   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Guatemala City Guatemala (1966)

Organization Overview

First Clinical Trial
2003
NCT00127504
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Universidad del Valle | Universidad del Valle de Guatemala (Antigua) | Universidad del Valle, Guatemala

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Diarrhea (Phase 2)

Helicobacter Infections (Phase 3)

HELLP Syndrome (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 4)

Onchocerciasis (Phase 2)

Syndrome (Phase 3)

Whooping Cough (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 13